Publications des événements indésirables
Catégories d’événements indésirables
Vous trouverez ci-dessous une liste d’articles publiés dans diverses revues médicales qui décrivent les recherches et les résultats en rapport avec l’inoculation Covid-19. [Anglais seulement]
Adenopathy
Adenopathy is any disease or inflammation that involves glandular tissue or lymph nodes. The term is usually used to refer to lymphadenopathy or swollen lymph nodes.
Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation
Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
Adenopathy Following COVID-19 Vaccination
Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up
Adverse Reaction Surveillance
Allergic and Anaphylactic Reactions
Practical handling of allergic reactions to COVID-19 vaccines
Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine
Anaphylaxis after Moderna COVID-19 vaccine
CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria
Allergic Reactions After COVID-19 Vaccination—Putting Risk Into Perspective
Acute Allergic Reactions to mRNA COVID-19 Vaccines
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine
Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine
Covid-19-vaksiner gir økt risiko for anafylaksi
Reported orofacial adverse effects of COVID-19 vaccines: The knowns and the unknowns
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
ANCA Glomerulonephritis
ANCA glomerulonephritis and vasculitis are rare autoimmune diseases, meaning that the body’s own immune system injures its cells and tissues. Vasculitis is a disorder where there is destruction of blood vessels by inflammation that affects both arteries and veins. Glomerulonephritis is a kind of kidney disease caused by inflammation in the glomeruli (the small blood vessels) in the kidneys.
ANCA glomerulonephritis after the Moderna COVID-19 vaccination
Autoimmune Disease
Autoimmune Hemolytic Anemia (red blood cells)
BCG Scar Reactivation
Bell's Palsy
Bell’s palsy is an unexplained episode of facial muscle weakness or paralysis. It begins suddenly and worsens over 48 hours. This condition results from damage to the facial nerve (the 7th cranial nerve). Pain and discomfort usually occur on one side of the face or head. Bell’s palsy can strike anyone at any age.
Left Bell’s palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report
Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence?
Adverse event reporting and Bell’s palsy risk after COVID-19 vaccination
Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report
Bell’s palsy following COVID-19 vaccination with high CSF antibody response
Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2
Bell’s palsy following COVID-19 vaccination: a case report
Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine
Bell’s palsy following COVID-19 vaccination
The association between COVID-19 vaccination and Bell’s palsy
Bilateral Facial Palsy
Bilateral facial palsy, AKA Facial Diplegia, is defined as facial paralysis or paresis affection both sides of the face, with onset being either completely simultaneous or the second side being affected within 30 days of the first side.
Bilateral Uveitis
HLA-B27–associated uveitis is most often characterized by recurrent anterior ocular inflammation in one eye at a time. Bilateral simultaneous disease is much less common and behaves differently from unilateral disease, with fewer recurrences.
Bilateral uveitis after inoculation with COVID-19 vaccine: A case report
“Breakthrough” Infections
Bursitis
Bursitis is inflammation of a bursa. A bursa is a closed, fluid-filled sac that works as a cushion and gliding surface to reduce friction between tissues of the body. The major bursae (this is the plural of bursa) are located next to the tendons near the large joints, such as in the shoulders, elbows, hips, and knees.
Cancer
Capillary Leak Syndrome
Central Nervous System
Chickenpox (Varicella-Zoster)
Children: Seriousness of disease and safety concerns
Death
Postmortem investigation of fatalities following vaccination with COVID-19 vaccines
Deaths associated with newly launched SARS-CoV-2 vaccination
Postmortem investigation of fatalities following vaccination with COVID-19 vaccines (post Mortem investigation)
Brain death in a vaccinated patient with COVID-19 infection (Brain)
Post-mortem findings in vaccine-induced thrombotic thombocytopenia (thrombocytopenia)
Fatal cerebral venous sinus thrombosis after COVID-19 vaccination (cerebral)
An Insight into the Role of Postmortem Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review (post-mortem, thrombosis)
Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2 Vaccination in Patient with Multiple Myeloma
Fatal hjerneblødning etter covid-19-vaksine
COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis
Post-mortem findings in vaccine-induced thrombotic thombocytopenia
Effectiveness of Messenger RNA (mRNA) vaccines
Effectiveness of covid-19 inoculation following cardiothoracic transplant
Effectiveness after Stem Cell Transplant
Encephalopathy
« Encephalopathy » means damage or disease that affects the brain. It happens when there’s been a change in the way your brain works or a change in your body that affects your brain. Those changes lead to an altered mental state, leaving you confused and not acting like you usually do.
Encephalitis (Autoimmune)
Encephalitis is inflammation of the brain. There are several causes, including viral infection, autoimmune inflammation, bacterial infection, insect bites and others. Sometimes there is no known cause.
Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
Encephalomyelitis
Eyes
Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report (with central retinal vein inclusion)
Ocular Adverse Events After COVID-19 Vaccination (Ocular)
Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2
Acute abducens nerve palsy following COVID-19 vaccination
Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine
Gastro
Graves' Disease
Facial Diplegia
Facial Nerve Palsy
Guillain-Barré Syndrome
Guillain-Barré (Ghee-YAN Bah-RAY) syndrome (GBS) happens when a person’s own immune system harms their body’s nerves. This harm causes muscle weakness and sometimes paralysis.
SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy
Guillain–Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination
A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination
A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN
Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report
COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination
Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report
Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine
Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2
A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine
Adenovirus COVID-19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Guillain-Barré syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: A case series
Guillian Barré syndromeafter mRNA-1273 vaccination against COVID-19
SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome
Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report
Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Hailey-Hailey Disease
Headache
Heart Lesion Test (PULS)
The PULS Cardiac Test is a blood test that identifies people who are seemingly healthy, but who have a high risk of Heart Disease. The test detects the early stages of Heart Disease. by detecting the initial arterial or endothelial injury. leading to unstable cardiac lesion rupture
Hematuria (Blood in Urine)
Hematuria is the presence of blood in a person’s urine. Gross hematuria is when a person can see the blood in his or her urine, and microscopic hematuria is when a person cannot see the blood in his or her urine, yet a health care professional can see it under a microscope.
Henoch-Schönlein Purpura
Henoch-Schonlein purpura (also known as IgA vasculitis) is a disorder that causes the small blood vessels in your skin, joints, intestines and kidneys to become inflamed and bleed. The most striking feature of this form of vasculitis is a purplish rash, typically on the lower legs and buttocks.
A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report
Hepatitis
Hepatitis is a general term used to describe inflammation of the liver. Liver inflammation can be caused by several viruses (viral hepatitis), chemicals, drugs, alcohol, certain genetic disorders or by an overactive immune system that mistakenly attacks the liver, called autoimmune hepatitis.
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination
Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report
Herpes
Any of a group of viral diseases caused by herpes viruses, affecting the skin (often with blisters) or the nervous system.
Heterogeneity
In genetics, the production of identical or similar phenotypes by different genetic mechanisms. A phenotype resembling a known phenotype but determined by a different genetic mechanism is called a genocopy or genetic mimic.
Hesitancy and Acceptance of mRna Inoculation
History of acute lymphoblastic leukemia and allergy to PEG-asparaginase
Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow.
Inoculation for people with pre-existing conditions
Kidney
Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?
Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination
Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2
Kidney Necrosis
Acute tubular necrosis is a condition that causes the lack of oxygen and blood flow to the kidneys, damaging them. Tube-shaped structures in the kidneys, called tubules, filter out waste products and fluid. These structures are damaged in acute tubular necrosis.
Kounis Syndrome
Kounis syndrome is the concurrence of acute coronary syndromes with conditions associated with mast cell activation, such as allergies or hypersensitivity and anaphylactic or anaphylactoid insults that can involve other interrelated and interacting inflammatory cells behaving as a ‘ball of thread’.
Type 1 Kounis Syndrome Induced by Inactivated SARS-COV-2 Vaccine
Limb Ischemia (blood blockage)
Blockage in the arteries of the lower extremities, which markedly reduces blood-flow. It is a serious form of peripheral arterial disease, or PAD, but less common than claudication.
Lobar Hemorrhage
A lobar hemorrhage occurs when there is bleeding into a lobe of the cerebrum.
Longitudinal Extensive Transverse Myelitis
Longitudinally extensive transverse myelitis (LETM) is a neurological condition characterised by a contiguous inflammatory lesion of the spinal cord. LETM is often associated with the autoimmune central nervous system disease neuromyelitis optica (NMO) and rarely with multiple sclerosis.
Lungs
Lymphadenopathy
Lymphadenitis is the medical term for enlargement in one or more lymph nodes, usually due to infection. Lymph nodes are filled with white blood cells that help your body fight infections. When lymph nodes become infected, it’s usually because an infection started somewhere else in your body.
Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination
Evolution of Lymphadenopathy at PET/MRI after COVID-19 Vaccination
Lymphadenopathy Associated With the COVID-19 Vaccine
A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19
Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation
Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination
Evolution of Lymphadenopathy at PET/MRI after COVID-19 Vaccination
Lymphadenopathy Associated With the COVID-19 Vaccine
A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19
COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram
COVID-19 Vaccination–Associated Lymphadenopathy on FDG PET/CT
Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review
COVID-19 mRNA Vaccination–Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT
COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan
Lymphohistiocytosis
Miller-Fisher Syndrome
Miller Fisher syndrome is a rare, acquired nerve disease that is considered to be a variant of Guillain-Barré syndrome. It is characterized by abnormal muscle coordination, paralysis of the eye muscles, and absence of the tendon reflexes.
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Multiple Sclerosis (MS)
Multisystem Inflammatory Syndrome
MIS is a rare but serious condition associated with COVID-19 in which different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.
Myelitis
Inflammation of the spinal cord.
Post COVID-19 transverse myelitis; a case report with review of literature
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19
Acute Transverse Myelitis Following COVID-19 Vaccination
Acute transverse myelitis after inactivated COVID-19 vaccine
Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature
Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report
SARS-CoV-2 Vaccination-Induced Transverse Myelitis
Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?
Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination
Myocardial Infarction (Heart Attack)
Myocarditis
A rare condition in which the heart muscle becomes thick and inflamed and may also become weak.
Myocarditis after BNT162b2 vaccination in a healthy male
Myocarditis Following mRNA COVID-19 Vaccine
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination
Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine
Myocarditis Associated with mRNA COVID-19 Vaccination
Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis
Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older
Myocarditis following COVID-19 vaccination: magnetic resonance imaging study
Acute myocarditis associated with COVID-19 vaccination: A case report
Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Myocarditis following COVID-19 vaccination – A case series
mRNA COVID vaccine and myocarditis in adolescents
Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
Myocarditis following COVID-19 vaccination
Myocarditis Following COVID-19 Vaccination
A review of COVID-19 vaccination and the reported cardiac manifestations
Myocarditis after vaccination against covid-19
A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines
Miocardite acuta in giovane adulto due giorni dopo vaccino Pfizer
A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
Myocarditis With COVID-19 mRNA Vaccines
Coronavirus and cardiovascular manifestations- getting to the heart of the matter
STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine
Acute myocardial infarction and myocarditis following COVID-19 vaccination
Myocarditis following COVID-19 vaccination
Myocarditis following COVID-19 mRNA vaccination
Myocarditis following mRNA vaccination against SARS-CoV-2, a case series
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Myocarditis following COVID-19 vaccination: magnetic resonance imaging study
Biventricular systolic dysfunction in acute myocarditis after SARS-CoV-2 mRNA-1273 vaccination
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination
A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2
The Anatolian Journal of Cardiology
Miocardite acuta in giovane adulto due giorni dopo vaccino Pfizer
Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination
Myocarditis after BNT162b2 vaccination in a healthy male
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man
Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older
Myocarditis associated with COVID‑19 vaccination in three male teenagers
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases
Myocarditis in the Setting of Recent COVID-19 Vaccination
Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
Acute myocarditis associated with COVID-19 vaccination: A case report
Myocarditis Temporally Associated With COVID-19 Vaccination
Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination
Myocarditis Associated With COVID-19 Vaccination
Acute myocarditis associated with anti-COVID-19 vaccination
Acute Myocarditis after COVID-19 vaccination: A case report
Myocarditis Associated with mRNA COVID-19 Vaccination
Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19
Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents
COVID-19 Vaccination–Associated Myocarditis in Adolescents
Myocarditis following COVID-19 vaccination – A case series
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
Myocarditis after COVID-19 mRNA vaccines
STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
Acute myocardial infarction and myocarditis following COVID-19 vaccination
Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn?
Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
Myocarditis Following mRNA COVID-19 Vaccine
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19
Myocarditis After SARS-CoV-2 Vaccination: A Vaccine-Induced Reaction?
In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine
Myocarditis Associated With COVID-19 Vaccination
COVID-19 vaccine-associated myocarditis/pericarditis
Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine
Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination
Clinical guidance for youth with myocarditis and pericarditis following mRNA COVID-19 Vaccination
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination
Myocarditis Associated with mRNA COVID-19 Vaccination
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
Myocarditis after Covid-19 mRNA Vaccination
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Myocarditis With COVID-19 mRNA Vaccines
Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
COVID-19 vaccines and myocarditis
COVID-19 Vaccine and Myocarditis
COVID-19 mRNA Vaccine and Myocarditis
A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man
Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination
Myocarditis after BNT162b2 vaccination in a healthy male
Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
Acute myocarditis following administration of BNT162b2 vaccine
Myopericarditis
A rare condition in which the heart muscle becomes thick and inflamed and may also become weak.
Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents
Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents
mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study
Acute Myopericarditis after COVID-19 Vaccine in Teenagers
A Case Report for Myopericarditis after BNT162b2 COVID-19 mRNA Vaccination in a Korean Young Male
Myositis
Myositis is an inflammation or swelling of the muscles. It is most often caused by injury, infection, medicines, or an autoimmune disorder.
Nephrotic Syndrome
Nephrotic syndrome is a group of symptoms that indicate your kidneys are not working properly. These symptoms include. too much protein in your urine, called proteinuria. low levels of a protein called albumin in your blood, called hypoalbuminemia. swelling in parts of your body, called edema.
New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review
Nephropathy
Nephropathy is a medical term for kidney disease. The type of kidney disease caused by diabetes is called diabetic nephropathy.
A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination
Neuritis
An inflammatory or degenerative lesion of a nerve marked especially by pain, sensory disturbances, and impaired or lost reflexes.
Neurologic Phantosmia
Qualitative olfactory dysfunctions, such as parosmia and phantosmia, may be clinical conditions secondary to neurological diseases. The incidence of parosmia is underestimated, as well as its association with neurological diseases, due to poor self-reporting of patients and lack of objective methods for its measure.
Neurological Complications
Neuropathies
A nerve problem that causes pain, numbness, tingling, swelling, or muscle weakness in different parts of the body. It usually begins in the hands or feet and gets worse over time.
Neuromyelitis Optica
Neuromyelitis optica (NMO), also known as Devic’s disease, is a rare condition where the immune system damages the spinal cord and the nerves of the eyes (optic nerves). NMO can affect anyone at any age, but it’s more common in women than men.
New-Onset Disease
Organ Rejection Post Inoculation
Pathophysiological Alterations
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
A case report: symptomatic pericarditis post-COVID-19 vaccination
Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines
Acute pericarditis and cardiac tamponade after Covid-19 vaccination
Perimyocarditis
Perimyocarditis is an acute inflammation of the pericardium and the underlying myocardium resulting in myocellular damage. It is usually asymptomatic with complete resolution in most cases. It can however lead to fulminant cardiac failure resulting in death or requiring cardiac transplantation.
Perimyocarditis Following COVID-19 Vaccination
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine
Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine
Perimyocarditis Following COVID-19 Vaccination
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine
Acute Myopericarditis after COVID-19 Vaccine in Teenagers
Acute Perimyocarditis Following First Dose of mRNA Vaccine Against COVID-19
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine
Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine
Phantosmia
An olfactory hallucination (phantosmia) makes you detect smells that aren’t really present in your environment. The odors detected in phantosmia vary from person to person and may be foul or pleasant. They can occur in one or both nostrils.
Polyangiitis
An inflammatory disease of small arteries and veins (vasculitis) that classically involves vessels supplying the tissues of the lungs, nasal passages (sinuses), and kidneys.
Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report
Polyarthralgia and Myalgia Syndrome
A medical condition where pain occurs in several joints of the body.
Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination
Pregnancy and Inoculation
Pulmonary Embolism
Pulmonary embolism (PE) occurs when a blood clot gets stuck in an artery in the lung, blocking blood flow to part of the lung. Blood clots most often start in the legs and travel up through the right side of the heart and into the lungs. This is called deep vein thrombosis (DVT).
A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization
COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism
COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism
Purpura Annularis Telangiectodes
Purpura annularis telangiectodes is a pigmented, purpuric eruption that occurs most commonly in adolescents and young adults. The disease is characterized by symmetrical, purpuric, telangiectatic, and atrophic patches, with a predilection for the lower extremities and buttocks.
Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine
Recurrence of Myopericarditis
Retinal Hemorrhage
Rhabdomyolysis
Safety, Efficacy, Immunogenicity
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Pfizer’s vaccine raises allergy concerns
Process-related impurities in the ChAdOx1 nCov-19 vaccine
An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history
Be Alert to the Risk of Adverse Cardiovascular Events after COVID-19 Vaccination
Severe Adverse Event group studies
Skin Reaction
Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination
A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination
Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report
Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature
Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV-19) vaccination
Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination
Cutaneous adverse effects of the available COVID-19 vaccines
Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19
Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine
Spectrum of Suspected Cardiomyopathy
Splenic Infarction
Socio-Economic Side Effects
Stroke
Sweet Syndrome
Systemic Capillary Leak Syndrome
Takotsubo Cardiomyopathy
T-Cells (with CD8)
Thrombocytopenia
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
SEVERE IMMUNE THROMBOCYTOPENIC PURPURA AFTER SARS-COV-2 VACCINE
Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
Relapse of immune thrombocytopenia after COVID-19 vaccination
Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination
A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series
VITT after ChAdOx1 nCoV-19 Vaccination
Vaccine-Induced Thrombocytopenia with Severe Headache
Thrombocytopenia in a teen with sickle cell disease following COVID-19 vaccination
A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination
Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine
Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine
Immune thrombocytopenia following vaccination during the COVID-19 pandemic
Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine
Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia
Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism
Thrombocytopenia after COVID-19 vaccination
Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine
Laboratory testing for suspected COVID-19 vaccine–induced (immune) thrombotic thrombocytopenia
Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia
PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia
Exacerbation of immune thrombocytopenia following COVID-19 vaccination
Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination
Thrombosis
Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines
Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine
Dyp venetrombose mer enn to uker etter vaksinering mot covid-19
mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis
COVID-19 vaccine-induced thrombosis
Deep Venous Thrombosis after Ad26.COV2.S Vaccination in Adult Male
Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination
Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness
Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination
Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination
Autoimmunity roots of the thrombotic events after COVID-19 vaccination
Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines
Thrombosis formation after COVID-19 vaccination Immunological Aspects: Review article
Thrombosis in pre- and post-vaccination phase of COVID-19
Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination
Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways
Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination
Hirnvenen- und Sinusthrombose nach COVID-19-Schutzimpfung
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines
Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination
Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis
A case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital
Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
Cerebral venous sinus thrombosis after vaccination: the UK experience
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome
Cutaneous thrombosis associated with skin necrosis following Oxford-AstraZeneca COVID-19 vaccination
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Cerebral venous sinus thrombosis after vaccination: the UK experience
Autoimmunity roots of the thrombotic events after COVID-19 vaccination
Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine
Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination
Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19
Fatal cerebral venous sinus thrombosis after COVID-19 vaccination
Cerebral Venous Thrombosis following COVID-19 Vaccination
Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine
Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia
Adenovirus-Vectored COVID-19 Vaccine–Induced Immune Thrombosis of Carotid Artery
Thyroiditis
Tolosa-Hunt Syndrome
Treatment
Type I Interferons
Vasculitis
Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination
Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2
Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination
Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine
Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report
Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report
Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination
Reactivation of IgA vasculitis after COVID-19 vaccination
Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis
Cutaneous vasculitis following COVID-19 vaccination
Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine
Reactivation of IgA vasculitis following COVID-19 vaccination
Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine
Leukocytoclastic vasculitis flare following the COVID-19 vaccine
Cutaneous small-vessel vasculitis following COVID-19 vaccine
New-onset leukocytoclastic vasculitis after COVID-19 vaccine
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
COVID-19 vaccine-induced urticarial vasculitis
Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report
Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine
Leukocytoclastic Vasculitis After Vaccination With a SARS-CoV-2 Vaccine
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine